We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Pelvic Floor Muscle Stimulator Treats Urinary Incontinence

By HospiMedica International staff writers
Posted on 29 Nov 2018
Print article
Image: Research shows that muscle stimulation can reduce incontinence (Photo courtesy of Atlantic Therapeutics).
Image: Research shows that muscle stimulation can reduce incontinence (Photo courtesy of Atlantic Therapeutics).
An externally worn stimulation device treats the root cause of stress urinary incontinence (SUI), rather than just managing the symptoms.

The Atlantic Therapeutics (Galway, Ireland) Innovo system is a non-invasive transcutaneous muscle exerciser, resembling a pair of cycling shorts, which uses electrical stimulation to deliver 180 precise, complete contractions to the pelvic floor muscles. During each 30-minute exercise session, the system strengthens and re-educates the network of muscles that control bladder function. A hand-held controller connected to the shorts allows users to increase the intensity of the stimulations, and a smartphone app is also available.

Innovo may be prescribed as a front-line therapy to those suffering SUI, or as a second line therapy to those that have previously failed physical therapy (in the form of supervised or unsupervised pelvic floor exercises, also known as Kegel exercises). A pivotal randomized controlled trial held in the United States demonstrated the efficacy and safety of the device, with 87.2% of patients treated dry or mild after a 12-week treatment period, and 93% experiencing improvement in just four weeks. An earlier sham-controlled trial in Europe also demonstrated significant improvement across all study endpoints.

“For the first time, physicians in the United States can offer their patients a safe, clinically effective, noninvasive home-based treatment,” said Steve Atkinson, CEO of Atlantic Therapeutics. “Innovo therapy is a compelling treatment option for all those women who today simply suffer in silence from stress urinary incontinence.”

“Innovo offers a new frontline therapeutic option for the millions of American women living with stress urinary incontinence, and in a significant group could delay or prevent the need for higher risk surgery or medical intervention,” said Elizabeth LaGro, vice president of The Simon Foundation for Continence (Wilmette, IL, USA).

SUI is the loss of bladder control or involuntary loss of urine when coughing, laughing, sneezing, or during heavy lifting, or simply getting up from a chair. SUI is the most common type of incontinence suffered by women, especially older women and women who have given birth. SUI also affects men, especially following prostate surgery. Other causes include weak pelvic muscles or a weak sphincter muscle; chronic coughing, smoking and obesity may also lead to SUI.

Related Links:
Atlantic Therapeutics

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
1.5T MRI Scanner
MAGNETOM Amira

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.